Taganov K D, Gushchin A E, Abramycheva N Iu, Govorun V M
Mol Gen Mikrobiol Virusol. 2000(2):30-3.
Nucleotide sequence of Acholeplasma laidlawii genome site PG-8B (1000 n.p.), containing topoisomerase IV subunit genes (parE and parC), has been determined. Sequenced genome site contains a gene fragment coding for the C-terminal region of ParE and gene fragment coding for N-terminal region of ParC. Topoisomerase IV subunite genes in A. laidlawii genome are situated near each other and overlapping by 4 nucleotides. Selection in liquid nutrient medium with ascending antibiotic concentrations resulted in derivation of A. laidlawii PG-8B cells resistant to ciprofloxacin, a fluoroquinolone. The resistant clones contain a mutation in the parC QRDR region determining fluoroquinolone resistance: Ser(91) (corresponding to Ser(80) in Escherichia coli ParC) replacement) for Leu.
已确定莱氏无胆甾原体基因组位点PG-8B(1000个核苷酸)的核苷酸序列,该位点包含拓扑异构酶IV亚基基因(parE和parC)。测序的基因组位点包含一个编码ParE C末端区域的基因片段和一个编码ParC N末端区域的基因片段。莱氏无胆甾原体基因组中的拓扑异构酶IV亚基基因彼此相邻,且重叠4个核苷酸。在抗生素浓度逐渐升高的液体营养培养基中进行筛选,得到了对氟喹诺酮类药物环丙沙星耐药的莱氏无胆甾原体PG-8B细胞。耐药克隆在决定氟喹诺酮耐药性的parC QRDR区域发生了突变:Ser(91)(对应于大肠杆菌ParC中的Ser(80))被Leu取代。